2020
DOI: 10.1158/1538-7445.sabcs19-p4-05-19
|View full text |Cite
|
Sign up to set email alerts
|

Abstract P4-05-19: Genome wide cell specification of R-loops in BRCA1 mutation carriers without malignancy

Abstract: An estimated 35,000 patients with breast cancer (BC) have pathogenic BRCA1/2 variants. Unfortunately, in the current state of medical practice, 50-80% of pathogenic mutation carriers remain undetected and undiagnosed. These are largely women with moderate penetrance mutations, including women with BRCA1 mutations, which may not have been identified. There is an unmet challenge to improve the identification and risks of patients who have an inherited increased lifetime risk of BC. BRCA1 mutation carriers (BRCA1… Show more

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles